Preferred Label : Citrullinemia, type II, adult-onset;
Symbol : CTLN2;
CISMeF acronym : CTLN2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Citrin deficiency;
Description : Adult-onset type II citrullinemia is an autosomal recessive metabolic disorder characterized
clinically by the sudden onset of various neuropsychologic symptoms such as disorientation,
abnormal behavior, convulsions, and coma due to hyperammonemia. In some cases, rapid
progression can lead to brain edema and death if liver transplantation is not possible.
Some patients may present with nonalcoholic hepatic steatosis or may develop hepatic
fibrosis or hepatocellular carcinoma. Patients with this disorder have a natural aversion
to carbohydrates and favor protein, which is in contrast to protein aversion usually
observed in patients with urea cycle defects (summary by Komatsu et al., 2008).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the solute carrier family 25 (mitochondrial carrier, citrin),
member 13 (SLC25A13, 603859.0001);
Neoplasia : Hepatocellular carcinoma;
Laboratory abnormalities : Hyperammonemia; Citrullinemia; Abnormal liver enzymes; Low serum albumin; Increased serum triglycerides; Increased serum pancreatic secretory trypsin inhibitor (PSTI); Secondary decreased activity of argininosuccinate synthetase (ASS1);
Prefixed ID : #603471;
Origin ID : 603471;
UMLS CUI : C1863844;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT